Biotechnological potential and genomic analysis of the Leuconostoc mesenteroides F17 and F18 strains isolated from camel milk

Camel milk is known for its distinctive nutritional and antimicrobial properties. Thus, it offers a valuable niche for discovering novel probiotic strains with potential health benefits. In this context, two Leuconostoc mesenteroides strains, F17 and F18 were isolated from this dairy matrix and thei...

ver descrição completa

Detalhes bibliográficos
Autores: Zeid, Ahmed Fouad, Zarour, K., Mohedano Bonillo, Mari Luz, Diez-Ozaeta, Iñaki, López García, Paloma
Tipo de documento: artigo
Estado:Versão publicada
Data de publicação:2025
País:España
Recursos:Consejo Superior de Investigaciones Científicas (CSIC)
Repositório:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/412389
Acesso em linha:http://hdl.handle.net/10261/412389
https://api.elsevier.com/content/abstract/scopus_id/105022226562
Access Level:Acceso aberto
Palavra-chave:Leuconostoc mesenteroides
Dextran
Dextransucrase
Lactic acid bacteria
Mannitol
Probiotic
Riboflavin
id ES_4aabdcc860d31d1f8effa2e5dbf6e175
oai_identifier_str oai:digital.csic.es:10261/412389
network_acronym_str ES
network_name_str España
repository_id_str
spelling Biotechnological potential and genomic analysis of the Leuconostoc mesenteroides F17 and F18 strains isolated from camel milkZeid, Ahmed FouadZarour, K.Mohedano Bonillo, Mari LuzDiez-Ozaeta, IñakiLópez García, PalomaLeuconostoc mesenteroidesDextranDextransucraseLactic acid bacteriaMannitolProbioticRiboflavinCamel milk is known for its distinctive nutritional and antimicrobial properties. Thus, it offers a valuable niche for discovering novel probiotic strains with potential health benefits. In this context, two Leuconostoc mesenteroides strains, F17 and F18 were isolated from this dairy matrix and their properties analysed. Also, to gain deeper insight into their probiotic and technological traits, the sequencing of the whole genomes of both strains was conducted, revealing key genetic features supporting their suitability as starter cultures. The two bacteria displayed desirable technological properties including among them rapid milk acidification capability as well as proteolytic and lipolytic activities. F17 and F18 produced riboflavin (0.11 and 0.15 mg/L) and exopolysaccharides (1.8 g/L and 3.7 g/L) characterized as dextran by physicochemical analysis. The F17 and F18 DsrD dextransucrases of ~ 170 kDa, responsible for the dextran synthesis, were visualized by a zymogram analysis and their dsrD coding genes, with 98.99% identity, were identified in their genomes. After 24 h growth in a sucrose-containing medium, analysis of metabolic fluxes in culture supernatants of both bacteria demonstrated accumulation of the sweetener mannitol and the antimicrobial lactic acid; at the levels of 59 mM and 76.57 mM in the case of the best performer (F18). Furthermore, the results demonstrated that both strains exhibited good survival rates under in vitro simulated stomach duodenum-passage. A high surface adhesion was also observed for F17 and F18 including hydrophobicity of 30.15% and 31.72% and auto-aggregation ability of 44.71% and 53.23%, with a good resistance to phenol exposure and to moderated heat shock. As expected from the genomes inspection, the safety analysis revealed that the two strains were susceptible to most of the tested antibiotics, and none of them showed any hemolytic activity or biogenic amines synthesis capability. Both cultures supernatants exhibited significant growth inhibition of foodborne pathogens, presumably due to the present of lactic acid. Thus, these findings suggest that camel milk may harbor lactic acid bacteria with promising technological and probiotic traits, as exemplified by F17 and F18.Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This research was funded by the Spanish Ministry of Science, Innovation and Universities [grants RTI2018-097114-B-I00 and PID2022-136874OB-C31] and two internships of A.F.Z. supported by the CSIC [grant I-COOP COOPA20488].Peer reviewedBioMed CentralConsejo Superior de Investigaciones Científicas (España)Ministerio de Ciencia, Innovación y Universidades (España)Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]202620262025info:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_6501Publisher's versioninfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://hdl.handle.net/10261/412389https://api.elsevier.com/content/abstract/scopus_id/105022226562reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)Inglés#PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE#info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTI2018-097114-B-I00info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2022-136874OB-C31COOPA20488https://doi.org/10.1186/s12866-025-04349-xSíinfo:eu-repo/semantics/openAccessoai:digital.csic.es:10261/4123892026-05-22T06:33:51Z
dc.title.none.fl_str_mv Biotechnological potential and genomic analysis of the Leuconostoc mesenteroides F17 and F18 strains isolated from camel milk
title Biotechnological potential and genomic analysis of the Leuconostoc mesenteroides F17 and F18 strains isolated from camel milk
spellingShingle Biotechnological potential and genomic analysis of the Leuconostoc mesenteroides F17 and F18 strains isolated from camel milk
Zeid, Ahmed Fouad
Leuconostoc mesenteroides
Dextran
Dextransucrase
Lactic acid bacteria
Mannitol
Probiotic
Riboflavin
title_short Biotechnological potential and genomic analysis of the Leuconostoc mesenteroides F17 and F18 strains isolated from camel milk
title_full Biotechnological potential and genomic analysis of the Leuconostoc mesenteroides F17 and F18 strains isolated from camel milk
title_fullStr Biotechnological potential and genomic analysis of the Leuconostoc mesenteroides F17 and F18 strains isolated from camel milk
title_full_unstemmed Biotechnological potential and genomic analysis of the Leuconostoc mesenteroides F17 and F18 strains isolated from camel milk
title_sort Biotechnological potential and genomic analysis of the Leuconostoc mesenteroides F17 and F18 strains isolated from camel milk
dc.creator.none.fl_str_mv Zeid, Ahmed Fouad
Zarour, K.
Mohedano Bonillo, Mari Luz
Diez-Ozaeta, Iñaki
López García, Paloma
author Zeid, Ahmed Fouad
author_facet Zeid, Ahmed Fouad
Zarour, K.
Mohedano Bonillo, Mari Luz
Diez-Ozaeta, Iñaki
López García, Paloma
author_role author
author2 Zarour, K.
Mohedano Bonillo, Mari Luz
Diez-Ozaeta, Iñaki
López García, Paloma
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Consejo Superior de Investigaciones Científicas (España)
Ministerio de Ciencia, Innovación y Universidades (España)
Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]
dc.subject.none.fl_str_mv Leuconostoc mesenteroides
Dextran
Dextransucrase
Lactic acid bacteria
Mannitol
Probiotic
Riboflavin
topic Leuconostoc mesenteroides
Dextran
Dextransucrase
Lactic acid bacteria
Mannitol
Probiotic
Riboflavin
description Camel milk is known for its distinctive nutritional and antimicrobial properties. Thus, it offers a valuable niche for discovering novel probiotic strains with potential health benefits. In this context, two Leuconostoc mesenteroides strains, F17 and F18 were isolated from this dairy matrix and their properties analysed. Also, to gain deeper insight into their probiotic and technological traits, the sequencing of the whole genomes of both strains was conducted, revealing key genetic features supporting their suitability as starter cultures. The two bacteria displayed desirable technological properties including among them rapid milk acidification capability as well as proteolytic and lipolytic activities. F17 and F18 produced riboflavin (0.11 and 0.15 mg/L) and exopolysaccharides (1.8 g/L and 3.7 g/L) characterized as dextran by physicochemical analysis. The F17 and F18 DsrD dextransucrases of ~ 170 kDa, responsible for the dextran synthesis, were visualized by a zymogram analysis and their dsrD coding genes, with 98.99% identity, were identified in their genomes. After 24 h growth in a sucrose-containing medium, analysis of metabolic fluxes in culture supernatants of both bacteria demonstrated accumulation of the sweetener mannitol and the antimicrobial lactic acid; at the levels of 59 mM and 76.57 mM in the case of the best performer (F18). Furthermore, the results demonstrated that both strains exhibited good survival rates under in vitro simulated stomach duodenum-passage. A high surface adhesion was also observed for F17 and F18 including hydrophobicity of 30.15% and 31.72% and auto-aggregation ability of 44.71% and 53.23%, with a good resistance to phenol exposure and to moderated heat shock. As expected from the genomes inspection, the safety analysis revealed that the two strains were susceptible to most of the tested antibiotics, and none of them showed any hemolytic activity or biogenic amines synthesis capability. Both cultures supernatants exhibited significant growth inhibition of foodborne pathogens, presumably due to the present of lactic acid. Thus, these findings suggest that camel milk may harbor lactic acid bacteria with promising technological and probiotic traits, as exemplified by F17 and F18.
publishDate 2025
dc.date.none.fl_str_mv 2025
2026
2026
dc.type.none.fl_str_mv info:eu-repo/semantics/article
http://purl.org/coar/resource_type/c_6501
Publisher's version
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/10261/412389
https://api.elsevier.com/content/abstract/scopus_id/105022226562
url http://hdl.handle.net/10261/412389
https://api.elsevier.com/content/abstract/scopus_id/105022226562
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv #PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTI2018-097114-B-I00
info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2022-136874OB-C31
COOPA20488
https://doi.org/10.1186/s12866-025-04349-x

dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv BioMed Central
publisher.none.fl_str_mv BioMed Central
dc.source.none.fl_str_mv reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC
instname:Consejo Superior de Investigaciones Científicas (CSIC)
instname_str Consejo Superior de Investigaciones Científicas (CSIC)
reponame_str DIGITAL.CSIC. Repositorio Institucional del CSIC
collection DIGITAL.CSIC. Repositorio Institucional del CSIC
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869407509375090688
score 15.812429